Kovack Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-333
| Closed | -$211K | – | 649 |
|
|
2025
Q1 | $211K | Buy |
333
+11
| +3% | +$6.98K | 0.02% | 523 |
|
|
2024
Q4 | $229K | Hold |
322
| – | – | 0.02% | 531 |
|
|
2024
Q3 | $338K | Sell |
322
-10
| -3% | -$10.5K | 0.04% | 413 |
|
|
2024
Q2 | $349K | Hold |
332
| – | – | 0.04% | 385 |
|
|
2024
Q1 | $320K | Hold |
332
| – | – | 0.04% | 330 |
|
|
2023
Q4 | $292K | Sell |
332
-3
| -0.9% | -$2.64K | 0.03% | 420 |
|
|
2023
Q3 | $276K | Buy |
335
+6
| +2% | +$4.94K | 0.04% | 414 |
|
|
2023
Q2 | $236K | Sell |
329
-51
| -13% | -$36.6K | 0.03% | 470 |
|
|
2023
Q1 | $312K | Buy |
380
+55
| +17% | +$45.2K | 0.04% | 403 |
|
|
2022
Q4 | $234K | Sell |
325
-10
| -3% | -$7.22K | 0.03% | 476 |
|
|
2022
Q3 | $231K | Sell |
335
-799
| -70% | -$551K | 0.03% | 479 |
|
|
2022
Q2 | $670K | Sell |
1,134
-521
| -31% | -$308K | 0.09% | 250 |
|
|
2022
Q1 | $1.16M | Buy |
1,655
+282
| +21% | +$197K | 0.12% | 178 |
|
|
2021
Q4 | $867K | Sell |
1,373
-108
| -7% | -$68.2K | 0.08% | 260 |
|
|
2021
Q3 | $896K | Buy |
1,481
+1,086
| +275% | +$657K | 0.1% | 237 |
|
|
2021
Q2 | $221K | Buy |
+395
| New | +$221K | 0.03% | 609 |
|
|
2020
Q3 | – | Sell |
-365
| Closed | -$228K | – | 522 |
|
|
2020
Q2 | $228K | Buy |
+365
| New | +$228K | 0.04% | 372 |
|
|
2019
Q2 | – | Sell |
-556
| Closed | -$228K | – | 466 |
|
|
2019
Q1 | $228K | Buy |
+556
| New | +$228K | 0.06% | 352 |
|
|
2018
Q4 | – | Sell |
-511
| Closed | -$206K | – | 452 |
|
|
2018
Q3 | $206K | Sell |
511
-230
| -31% | -$92.7K | 0.05% | 385 |
|
|
2018
Q2 | $256K | Sell |
741
-255
| -26% | -$88.1K | 0.07% | 314 |
|
|
2018
Q1 | $343K | Buy |
996
+199
| +25% | +$68.5K | 0.09% | 265 |
|
|
2017
Q4 | $300K | Sell |
797
-320
| -29% | -$120K | 0.08% | 306 |
|
|
2017
Q3 | $499K | Buy |
1,117
+20
| +2% | +$8.94K | 0.17% | 146 |
|
|
2017
Q2 | $539K | Sell |
1,097
-1,279
| -54% | -$628K | 0.17% | 150 |
|
|
2017
Q1 | $921K | Buy |
2,376
+1,424
| +150% | +$552K | 0.36% | 57 |
|
|
2016
Q4 | $349K | Buy |
+952
| New | +$349K | 0.17% | 148 |
|